NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) - ANVISA Registration 82568320011

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 82568320011 and manufactured by manufacturer not specified. The registration is held by GLOBALX TECNOLOGIA BRASIL LTDA with validity until Mar 31, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including ABBOTT RAPID DIAGNOSTICS JENA GMBH, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
2 Competitors
82568320011
2 Related Devices
Registration Details
ANVISA Registration Number: 82568320011
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

82568320011

25351360902202429

41775241000190

Company Information

Dates and Status

Mar 31, 2025

31/03/2035

09/18/2025 19:00:01

Registration Details

82568320011

25351360902202429

41775241000190

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Mar 31, 2025

31/03/2035

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2)"